---
title: "Ranolazine - Angina Pectoris"
sidebar: mydoc_sidebar
permalink: db00243-mesh-d000787-1.html
toc: false 
---


Path ID: `DB00243_MESH_D000787_1`
{% include image.html url="images/db00243-mesh-d000787-1.png" file="db00243-mesh-d000787-1.png" alt="db00243-mesh-d000787-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000069458 | ranolazine | Drug |
| InterPro:IPR010526 | Sodium ion transport-associated | GeneFamily |
| GO:0060402 | calcium ion transport into cytosol | BiologicalProcess |
| HP:0005162 | Abnormal left ventricular function | PhenotypicFeature |
| MESH:D000787 | Angina pectoris | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Ranolazine | DECREASES ACTIVITY OF | Sodium Ion Transport-Associated |
| Sodium Ion Transport-Associated | POSITIVELY REGULATES | Calcium Ion Transport Into Cytosol |
| Calcium Ion Transport Into Cytosol | CORRELATED WITH | Abnormal Left Ventricular Function |
| Abnormal Left Ventricular Function | POSITIVELY CORRELATED WITH | Angina Pectoris |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00243#BE0004901](https://go.drugbank.com/drugs/DB00243#BE0004901)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/56959#section=Mechanism-of-Action](https://pubchem.ncbi.nlm.nih.gov/compound/56959#section=Mechanism-of-Action)
  - [https://pubmed.ncbi.nlm.nih.gov/26979079/](https://pubmed.ncbi.nlm.nih.gov/26979079/)
